Neurological symptoms and signs in HTLV-1 patients with overactive bladder syndrome
Costa, Davi Tanajura; Santos, André Luiz Muniz Alves dos; Castro, Néviton Matos de; Siqueira, Isadora Cristina de; Carvalho Filho, Edgar Marcelino de; Glesby, Marshall Jay.
; 70(4): 252-256, Apr. 2012. tab
Artigo em Inglês | LILACS | ID: lil-622587
Neurological symptoms and signs in HTLV-1 patients with overactive bladder syndrome.
The use of botulinum toxin type A in the treatment of HTLV-1-associated overactive bladder refractory to conventional therapy
The use of botulinum toxin type A in the treatment of HTLV-1-associated overactive bladder refractory to conventional therapy.
Immunological and viral features in patients with overactive bladder associated with human T-cell lymphotropic virus type 1 infection.
Retrospective clinic and urodynamic study in the neurogenic bladder dysfunction caused by human T cell lymphotrophic virus type 1 associated myelopathy/tropical spastic paraparesis (HAM/TSP).
Immunopathogenesis and neurological manifestations associated to HTLV-1 infection
Infective Dermatitis in an Adult Patient With HTLV-1.
Cognitive impairment in HTLV-1-associated myelopathy, proviral load and inflammatory markers.
HTLV-1 subgroups associated with the risk of HAM/TSP are related to viral and host gene expression in peripheral blood mononuclear cells, independent of the transactivation functions of the viral factors.
Human T cell lymphotropic virus type 1 (HTLV-1) proviral load of HTLV-associated myelopathy/tropical spastic paraparesis (HAM/TSP) patients according to new diagnostic criteria of HAM/TSP.